The Automated Memory and Executive Screening (AMES) tool, introduced by Huang et al. (2023), represents a significant step in identifying early cognitive decline. Designed for use in primary care settings, AMES evaluates cognitive domains such as memory, language, and executive function. This post reviews the study’s findings and the tool’s …
Bredesen’s 2014 study introduces an innovative approach to addressing cognitive decline, particularly in conditions such as Alzheimer’s disease. This research explores a multi-modal therapeutic framework called Metabolic Enhancement for Neurodegeneration (MEND), highlighting its potential to improve cognitive abilities in early-stage cases. The findings are promising yet warrant further investigation to …
